Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) [Phase 1]
A Phase 1 clinical trial update for the V934/V935 cancer vaccine (V934-002) in selected solid tumors; the study is completed and results hav…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial update of PEG-interferon alfa-2b in patients with stage IV melanoma.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma [Phase 2]
Phase 2 study of GSK2118436 (dabrafenib) in patients with BRAF-mutant metastatic melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma [NA]
This entry notes completion of a clinical trial evaluating lymphodepletion followed by adoptive cell transfer with high-dose interleukin-2 i…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy
A terminated clinical trial evaluated lymphokine-activated killer cytotoxicity in patients undergoing interleukin-2 therapy for melanoma and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating a vaccine therapy for stage II melanoma patients eligible for surgical resection has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
This Phase 2 trial evaluates a vaccine therapy with or without interleukin-12 in patients with stage III/IV melanoma, including intraocular …
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Novel Adjuvants for Peptide-Based Melanoma Vaccines [Phase 1]
This update notes that a Phase 1 trial evaluating novel adjuvants for peptide-based melanoma vaccines has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma [Phase 2]
A Phase 2 vaccine therapy trial in melanoma patients with Stage IIC to IV disease has completed. The trial encompassed intraocular subtypes …
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
This clinical trial update notes a Phase 2 study of vaccine therapy followed by a biological therapy for stage III or stage IV melanoma, whi…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating vaccine therapy with interleukin-12 after surgery in melanoma patients, using either alum (alumin…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial of a vaccine therapy for metastatic melanoma has completed, including patients with intraocular melanoma and cutaneous melan…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) [Phase 1]
Phase I trial evaluating the combination of ipilimumab and vemurafenib in BRAF-mutant melanoma terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma [Phase 3]
Phase 3 trial comparing GSK2118436 (dabrafenib) to dacarbazine in previously untreated BRAF mutation-positive advanced or metastatic melanom…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Tailored Intervention for Melanoma Patient's Families [NA]
This entry notes that the clinical trial titled 'Tailored Intervention for Melanoma Patient's Families' sponsored by Fox Chase Cancer Center…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma [Phase 1]
A Phase 1 trial evaluating the safety and immunogenicity of a patient-derived autologous mRNA electroporated dendritic cell vaccine, given b…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma [Phase 1]
A Phase 1 trial evaluating a vaccine therapy following therapeutic autologous lymphocytes and cyclophosphamide in metastatic melanoma has co…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies [Phase 2]
A Phase 2 companion study evaluating patients previously enrolled in ipilimumab trials for melanoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma [Phase 1]
A Phase 1 study examining the combination of sorafenib and temsirolimus in patients with metastatic, recurrent, or unresectable melanoma has…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor [Phase 2]
A Phase 2 trial evaluating the MEK inhibitor GSK1120212 (trametinib) in patients with BRAF mutation-positive melanoma previously treated wit…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating the combination of everolimus with paclitaxel and carboplatin in metastatic melanoma has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma [Phase 1]
Phase 1 study evaluating GC1008 (fresolimumab), a TGF-beta antagonist, for safety and preliminary efficacy in renal cell carcinoma and malig…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma [Phase 3]
A Phase 3 trial evaluating ipilimumab plus dacarbazine versus dacarbazine with placebo in untreated unresectable stage III or IV melanoma ha…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus peripheral stem cell transplantation in melanoma or metastatic kidney cancer has complet…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Characterization of Brain Metastases
The document reports the completion status of a clinical trial characterizing brain metastases across cancers including lung cancer, breast …